In this audio interview, Moira Gunn speaks with Neville McClenaghan about Diabetica Limited's innovative approach to treating diabetes and the link between this disease and obesity.
Dr. Moira Gunn speaks with Vical Vaccines' President & CEO, Vijay Samant. Samant explains why there are so few vaccines available, and how Vical is focussing its efforts on making vaccines that can be effective in third world environments.
Dr. Moira Gunn speaks with David Zimmerman, CEO of Kalexsyn. Zimmerman discusses Kalamazoo, Michigan, a typical Midwest American town - until all the plants closed. The answer was Biotech.
Dr. Moira Gunn speaks with Dr. Jim Frank, Director of Biotechnology and Biodefense Applications at Argonne National Laboratories. He tells us that there's much, much more to biotech than personalized medicine.
Dr. Moira Gunn speaks with Dr. Rick Jones, Vice President for Product Development at BioRexis Pharmaceutical Corporation. He reviews many of the new breakthroughs in treating diabetes.
Dr. Moira Gunn speaks with Dr. Hilary Koprowski, a Professor of Immunology at Thomas Jefferson University. You may not know his name, but half a century ago, he created the live polio vaccine.
Dean Kamen has literally changed the world by turning breakthrough ideas into practical products. In this audio interview with Globeshakers host Tim Zak, Kamen discusses the power of technology to change society. He also talks about what it takes to persevere in the face of public and professional resistance toward inventions and technology that can actually make people's lives better.
On BioTech Nation, Dr. Moira Gunn interviews Mary Del Brady, the President & CEO of Redpath Integrated Pathology. She reveals a new scientific technique for diagnosing pancreatic cancer. On then on the BioIssue of the Week, David Ewing Duncan talks about the questionable value of knowing your DNA.
Dr. Moira Gunn speaks with Robert "Al" Beardsley, the President and CEO of Kereos. He talks about their cancer research -- and how it fits in the field of nanotech. Then on the BioIssue of the Week, David Duncan will give us the expert's view on a reasonable timeline to expect results from today's stem cell research.
On BioTech Nation, Dr. Moira Gunn speaks with Dr. Mahendra Rao, the Vice President of Research in Regenerative Medicine and Stem Cell Technologies for Invitrogen. He'll tell us how a stem cell line dies out, and what this means for the Presidential Stem Cell Lines, the only ones approved for federal funding. Then on the BioIssue of the Week, we'll find out why the 2004
California Stem Cell Initiative appears to be in limbo.